RxDoctor Payments Data
★ My doctorsLook up a doctor →

Richard Shubin

Neurology · Arcadia, CANPI 1265442180

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $138,287 of the $189,041 with a category attached, or 73.2%. 56 manufacturers reported payments, led by Novartis at 24.5% of the total. Reporting peaked in 2019 at $91,142 and has fallen 100.0% since, to $15 in 2024. Among neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$189,041in general payments, 2019–2025

Across 720 payments — averaging $262.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$46K
  • Sanofi$38K
  • Biogen$35K
  • Teva Pharmaceuticals USA, Inc.$15K
  • Genentech USA, Inc.$11K
  • Bristol Myers Squibb$10K
  • plus $34K from 50 others
$1,782,189in research payments, 2019–2025

Across 160 payments — averaging $11,139 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$1.3M
  • Novartis$100K
  • Amneal Pharmaceuticals LLC$64K
  • Eli Lilly$61K
  • AbbVie$59K
  • F. Hoffmann-la Roche AG$48K
  • plus $166K from 7 others

What the payments were for

  • Consulting fees$28,57315%
  • Speaking & faculty fees$138,28773%
  • Travel & lodging$8,8845%
  • Food & beverage$12,8617%
  • Education$4370%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis121$46,255
Sanofi85$37,829
Biogen63$34,626
Teva Pharmaceuticals USA, Inc.61$15,489
Genentech USA, Inc.24$10,815
Bristol Myers Squibb14$10,108
Johnson & Johnson10$7,636
Amneal Pharmaceuticals LLC18$7,292
AbbVie(2 entities)16$7,158
UCB, Inc.38$2,978
Harmony Biosciences LLC6$1,485
Janssen Research & Development, LLC1$1,133
EMD Serono, Inc.17$911
Amgen(2 entities)30$607
AstraZeneca20$476
Acadia Pharmaceuticals Inc21$435
Lundbeck LLC13$282
Avanir Pharmaceuticals, Inc.12$224
Inspire Medical Systems, Inc.1$198
Eisai Inc.3$174
Alnylam Pharmaceuticals Inc.7$169
Sanofi-aventis U.S. LLC5$163
Takeda Pharmaceuticals U.S.A., Inc.14$158
Biohaven Pharmaceuticals, Inc.7$155
Abbott5$141
Mallinckrodt Hospital Products Inc.5$141
Grifols USA, LLC5$132
Adamas Pharmaceuticals, Inc.7$131
Lilly USA, LLC8$128
Mallinckrodt Enterprises LLC7$116
Akcea Therapeutics, Inc.5$113
Acorda Therapeutics, Inc5$105
Almatica Pharma LLC4$102
E.r. Squibb & Sons, L.L.C.5$93
Zyla Life Sciences, Inc.7$90
Jazz Pharmaceuticals Inc.5$86
SK Life Science, Inc.4$81
CSL Behring4$73
Greenwich Biosciences, Inc.3$73
MDD US Operations, LLC4$70
Vertical Pharmaceuticals, LLC4$67
Kyowa Kirin, Inc.3$65
Assertio Therapeutics, Inc.4$62
Arbor Pharmaceuticals, Inc.3$54
Vanda Pharmaceuticals Inc.2$47
Bausch Health US, LLC2$40
Genentech, Inc.1$40
Livanova USA, Inc.1$35
Neurocrine Biosciences, Inc.2$34
Pfizer2$33
Upsher-smith Laboratories LLC1$23
Promius Pharma LLC1$23
Portola Pharmaceuticals, LLC1$22
Merck1$22
Medtronic1$19
Aquestive Therapeutics, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$189,041 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Other neurology in Arcadia

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →